West Syndrome Market Share

  • Report ID: 4397
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

West Syndrome Market Share

North American Market Forecast   

North America industry is set to hold largest revenue share by 2037. The growth of the market can be attributed majorly to the escalation in the number of people living with traumatic brain injuries. For instance, in 2020, more than 60,000 people lost their lives due to traumatic brain injuries solely in the USA while approximately 150 death occurs on a daily basis in the same region. The increasing number of accidents on road cause brain damage or brain injury. The growing number of brain surgeries owing to infection, cancer, or side effect of any disease are estimated to rise market growth. Accidents in sports are also rising owing to the increasing preference of people for fitness and physical activity. Brain diseases can also be caused by genetic disorders that occur during birth.

APAC Market Statistics

Moreover, the second largest market share is occupied by the Asia Pacific region. The growth of the market is attributed to the increasing prevalence of diseases, improvement in the healthcare sector, and growing awareness of treatment among people. The rising healthcare infrastructure and facilities in the countries of the Asia Pacific region including China and India play a major role in the market growth. As per the research, it is reported that the healthcare expenditure of China in 2020 was estimated to be USD 1 trillion

Research Nester
Flexible-Plastic-Packaging-Coating-Market-Regional.jpg
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4397
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of west syndrome is estimated at USD 1.21 billion.

The west syndrome market size was valued at USD 1.11 billion in 2024 and is likely to cross USD 2.17 billion by 2037, registering more than 5.3% CAGR during the forecast period i.e., between 2025-2037. Higher prevalence of drug seizures and significant growth in imaging technology will boost the market growth.

North America industry is set to hold largest revenue share by 2037, attributed to escalation in the number of people living with traumatic brain injuries.

The major players in the market are Marinus Pharmaceuticals, Inc., SK Biopharmaceuticals Co., Ltd., Alkem Laboratories Ltd., Supernus Pharmaceuticals, Inc., Eisai Co., Ltd., Abbott Laboratories, Upsher-Smith Laboratories, LLC., Pfizer Inc., H. Lundbeck A/S, UCB S.A.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample